摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-[(Dimethylamino)methyl]-19-ethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

中文名称
——
中文别名
——
英文名称
8-[(Dimethylamino)methyl]-19-ethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
英文别名
8-[(dimethylamino)methyl]-19-ethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
8-[(Dimethylamino)methyl]-19-ethyl-7-hydroxy-19-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione化学式
CAS
——
化学式
C24H25N3O5
mdl
——
分子量
435.5
InChiKey
TZESFDUVZNCASF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    32
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    92.2
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • Cyclic peroxides as prodrugs for selective delivery of agents
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US11014955B2
    公开(公告)日:2021-05-25
    Disclosed herein, inter alia, are prodrug compositions and methods of using the same for treatment and detection of disease. Specifically, disclosed herein is a compound of formula (I) having spiro-fused 1,2,4-trioxolane and piperidine rings, namely, 1,2,4-trioxa-8-azaspiro[4.5] decane. Also disclosed is a pharmaceutical composition containing the compound and a pharmaceutically acceptable carrier.
    本文特别公开了原药组合物以及使用原药组合物治疗和检测疾病的方法。具体地说,本文公开了一种具有螺融合 1,2,4-三氧环和哌啶环的式 (I) 化合物,即 1,2,4-三氧杂-8-氮杂螺[4.5]癸烷。还公开了一种药物组合物,其中含有该化合物和一种药学上可接受的载体。
  • CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20200317714A1
    公开(公告)日:2020-10-08
    Disclosed herein, inter alia, are prodrug compositions and methods of using the same for treatment and detection of disease. Specifically, disclosed herein is a compound of formula (I) having spiro-fused 1,2,4-trioxolane and piperidine rings, namely, 1,2,4-trioxa-8-azaspiro[4.5] decane. Also disclosed is a pharmaceutical composition containing the compound and a phannaceutically acceptable carrier.
查看更多

同类化合物